For Immediate Release
5 December 2016
Think Tank urges action to improve uptake of Shingles Vaccine among older people
Responding to the news of falls in uptake of the shingles vaccination, the International Longevity Centre UK (ILC-UK) has urged a change to its eligibility guidelines.
Public Health England has reported a decline in the uptake of the Shingles vaccination in both the routine (70 year old) and catch up (78 years old) cohorts (from 61.8% in 2013/14 to 54.9% in 2015/16 and from 57.8% in 2014/15 to 55.5% in 2015/16, respectively).
In 2013, ILC-UK published “Immune Response”, calling for a lifecourse approach to immunisation and making 30 plus recommendations for policy action.
In 2015, ILC-UK launched a European Adult Immunisation Hub, which seeks to provide information and news about adult immunisation across Europe.
David Sinclair, Director, ILC-UK and Editor of the European Adult Immunisation Hub said:
“Vaccination is not just for kids. In an ageing society we need a much greater focus on improving awareness and uptake of vaccination among adults.
Anything we can do to reduce likelihood of pain is of huge importance in old age, with 6 in 10 people in their mid-70s suffering from pain.
Shingles can be a significant cause of pain in old age and vaccination is an effective way of reducing the likelihood that we will suffer from it. We must ensure that older people eligible for the Shingles vaccination take up their right to receive it.
Some parts of the country have very low coverage of the Shingles vaccine among eligible people. It is important that Public Health England and the Department of Health work to ensure that we don’t see emerging a postcode lottery in access to the vaccine.
The complexity of the age of eligibility guidelines for shingles will no doubt be hampering the ability to communicate uptake to relevant individuals. Perhaps now is the time to extend eligibility to everyone between 70 and 80, after all, all of these people are at risk and would benefit from vaccination.”
Details of who is eligible for a shingles vaccine are available here: http://www.nhs.uk/Conditions/vaccinations/Pages/who-can-have-the-shingles-vaccine.aspx
See the European Adult Immunisation Website for more information about the latest figures for Shingles uptake: http://www.adultimmunisation.eu/shinglesherpes-zoster/shingles-vaccination-uptake-falls-england/
David Eaton (email@example.com) 02073400440 or 07851042609
The International Longevity Centre – UK (ILC-UK) is a futures organisation focussed on some of the biggest challenges facing Government and society in the context of demographic change.
The European Adult Immunisation Hub is available at: http://www.adultimmunisation.eu/.
Date :05 December 2016
ILC-UK Chief Executive Baroness Greengross has been presented a special Lifetime Achievement award by HRH The Prince of Wales, on behalf of the British Geriatrics Society.
Date :20 March 2017
The latest information on ILC-UK events, research and analysis.
Date :10 March 2017
Previous ILC-UK Research (1) has shown how household spending steadily falls as we get older.
Today’s “Family Spending” (2) evidence from ONS, shows a similar trend, with households headed by a person aged 75 and over spending substantially less than their younger counterparts.
Date :17 February 2017
Research finds that although 9 in 10 65-79 year olds live in under occupied houses, there could be a retirement housing gap of 160,000 houses by 2030 if Government fails to focus on last time buyers
Date :07 February 2017
We need a Research Fellow with excellent analytical ability and strong writing skills who has a passion for, and understanding of, UK public policy.
Date :26 January 2017
We need an economic analyst to lead on quantitative economic research projects, to feed their analysis into the wider work of the team, and to communicate research findings via engagement with policymakers and media.
Date :26 January 2017